China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective cohort study on biological indicators for predicting the effectiveness of allergen-specific immunotherapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135745
Registration Time: 2026/11/02
Type: Observational study
Primary Sponsor: Chongqing General Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=306123
Published by HT Digital Content Services with permission from Health Daily Digest....